Roche

Genentech/hoffmann la-Roche and Shanghai Henlius Biotech/Organon settle pertuzumab BPCIA case JD Supra15:33Genentech Biotech Biotechnology

Genentech and Shanghai Henlius Biotech settle Perjeta® biosimilar BPCIA litigation JD Supra16:04Genentech Biotech Biotechnology

Roche reports upbeat efficacy data from Phase II obesity study Zacks10:24

Roche's obesity drug helps almost 87% people lose at least 10% weight Benzinga06:30

Data builds on Roche's dominance in primary progressive ms pharmaphorum07:48Multiple Sclerosis Pharma Health

Roche’s 2025 profit blunted by weakened US dollar Pharmaceutical Technology11:10Switzerland Pharma

RHHBY's 2025 results hit by currency headwinds, sales up 7% at cer Zacks10:54Switzerland Pharma

Roche reports solid rise in earnings, cautious on outlook ShareCast07:51Pharma

These 2 companies could soon join the weight loss market: Are they buys? The Motley Fool11:16Mounjaro Pharma Ozempic

Roche, trailing in obesity, showcases new data for GLP-1 shot BioPharma Dive11:50

STAT Plus: Pharmalittle: We’re reading about a Roche obesity drug, a clash over 340B claims… STAT09:20

Latest News

Yesterday

Subcutaneously Administered Nanotrastuzumab Matches Performance Of Herceptin HYLECTA In Minipig … Pharmaceutical Online12:27 12-Feb-26

In the last 7 days

Data builds on Roche's dominance in primary progressive MS pharmaphorum07:48 9-Feb-26

Roche’s fenebrutinib demonstrates decade-first benefit in multiple sclerosis European Pharmaceutical Review07:43 9-Feb-26

Roche Diagnostics Korea outlines automation, AI roadmap for laboratories Korea Biomedical Review00:28 9-Feb-26

Fierce Pharma Asia—Amgen, Kyowa's OX40 divorce; Roche's RNAi deal; Daiichi's ADC cull FiercePharma09:52 6-Feb-26

In the last month

Genentech/Hoffmann La-Roche and Shanghai Henlius Biotech/Organon Settle Pertuzumab BPCIA Case JD Supra15:33 5-Feb-26

These 2 Companies Could Soon Join the Weight Loss Market: Are They Buys? The Motley Fool11:16 5-Feb-26

Genentech and Shanghai Henlius Biotech Settle Perjeta® Biosimilar BPCIA Litigation JD Supra16:04 4-Feb-26

Sali Hughes on beauty: why cica creams belong in every first-aid kit Yahoo! UK & Ireland05:07 4-Feb-26

Roche Awaits Key Readouts In 2026 – Including Its Potential Biggest Ever Drug Scrip Pharma Intelligence13:02 30-Jan-26

Roche Settles Perjata Patent Suit on Organon, Henlius Biosimilar Bloomberg Law12:58 30-Jan-26

Labcorp Collaborates With Roche To Bring Fully Automated Mass Spectrometry To U.S. Clinical Labs Laboratory Network07:09 30-Jan-26

Roche Earnings: Continuing Steady Underlying Growth in 2026 as Late-Stage Pipeline Shines Morningstar05:38 30-Jan-26

Roche CEO To Switzerland: You Need To Adapt To Pharma’s New World Order Scrip Pharma Intelligence11:34 29-Jan-26

Roche’s 2025 profit blunted by weakened US dollar Pharmaceutical Technology11:10 29-Jan-26

RHHBY's 2025 Results Hit by Currency Headwinds, Sales Up 7% at CER Zacks10:54 29-Jan-26

Roche Sees Steady 2026 Growth As Key Drugs Post Double-Digit Gains Benzinga10:48 29-Jan-26

Roche reports solid rise in earnings, cautious on outlook ShareCast07:51 29-Jan-26

Roche GLP-1 produces “robust” weight loss in late-stage obesity trial European Pharmaceutical Review07:19 29-Jan-26

DUB Inhibitors Market to Witness Strong Expansion Across 7MM by 2040 Driven by the Launch of… PR Newswire (Press Release)17:32 28-Jan-26

Roche Reports Upbeat Efficacy Data From Phase II Obesity Study Zacks10:24 28-Jan-26

Roche launches AI-enabled predictive CGM solution for diabetes management in Middle East BioSpectrum Asia08:39 28-Jan-26

Roche, trailing in obesity, showcases new data for GLP-1 shot BioPharma Dive11:50 27-Jan-26

Roche Eyes CT-388 Phase III Trial After Promising Obesity Data Scrip Pharma Intelligence09:36 27-Jan-26

STAT Plus: Pharmalittle: We’re reading about a Roche obesity drug, a clash over 340B claims… STAT09:20 27-Jan-26

Roche claims midstage win for obesity injectable pharmaphorum07:05 27-Jan-26

Roche's Obesity Drug Helps Almost 87% People Lose At Least 10% Weight Benzinga06:30 27-Jan-26

STAT Plus: Roche moves obesity drug to pivotal trials after mid-stage success STAT03:13 27-Jan-26

Roche announces positive Phase II results for obesity drug CT-388 Investing.com02:55 27-Jan-26

Roche announces positive phase II results for dual GLP-1/Gip receptor Yahoo! US01:23 27-Jan-26

Genentech Announces Positive Phase II Results for Its Dual GLP-1/Gip Receptor Agonist CT-388 in … Business Wire (Press Release)01:11 27-Jan-26

Biotech Giant Roche To Triple Investment Footprint on Harvard’s Enterprise Research Campus The Harvard Crimson23:41 25-Jan-26

Next-generation obesity drug from Chugai and Roche aims to stop rebounds Nikkei Asian Review11:41 25-Jan-26

Roche Head Of Pharma Strategy Karsten Jung On Rebuilding The Portfolio Scrip Pharma Intelligence14:03 22-Jan-26

Genentech To Double Its Investment At North Carolina Drug Manufacturing Facility Pharmaceutical Online09:05 22-Jan-26

NICE backs Roche lupus drug that supports kidney function pharmaphorum07:05 22-Jan-26

Roche's Genentech Expands Investment in North Carolina Facility to $2B Zacks12:47 21-Jan-26

Swiss giant Roche vows to double spending at Wake County obesity drug site News & Observer, North Carolina14:31 20-Jan-26

Roche's Genentech more than doubles investment in North Carolina facility to about $2 billion Yahoo! US11:25 20-Jan-26

Genentech More than Doubles Investment in Holly Springs, North Carolina Manufacturing Facility Business Wire (Press Release)10:33 20-Jan-26

ImmunityBio Shares Surge on Updated Durable Lymphoma Study Results Zacks11:40 19-Jan-26

Goldman Sachs raises Roche to “neutral” on trial wins, lifts PT to CHF365 Investing.com03:46 16-Jan-26

Deep Bio trims headcount and leans on Roche, PathAI to speed US prostate pathology sales Korea Biomedical Review20:39 13-Jan-26

view more headlines

12 Feb 12:27

Roche News

NewsNow brings you the latest news from the world’s most trusted sources on Roche pharmaceuticals, a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. NewsNow aims to be the world’s most accurate and comprehensive Roche news aggregator, bringing you the latest headlines automatically and continuously 24/7.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.